Skip to main content

Lab Notes: Venatorx closes Series C financing; Ocugen takes 'critical' step in clinical trial

A Conshohocken firm received approval for a cancer therapy from the European Commission.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.